Real-time enrollment status for this retinitis pigmentosa (rp) clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:23 PM UTC
| NCT Number | NCT07710196 |
| Recruiting Status | Recruiting |
| Condition | Retinitis Pigmentosa (RP) |
| Phase | PHASE3 |
| Target Enrollment | 80 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nacuity Pharmaceuticals, Inc. |
| Last Updated on CT.gov | October 13, 2026 (2 days ago) |
As of October 15, 2026: Clinical trial NCT07710196 is currently recruiting participants. This phase3 study for retinitis pigmentosa (rp) is actively seeking new participants at 1 location across the United States. The study is sponsored by Nacuity Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07710196 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07710196 was last updated 2 days ago (October 13, 2026). HelloStudys verifies this status automatically.